In a review of the evidence regarding benzodiazepines, researchers from the University of Michigan find that benzodiazepines used in the treatment of PTSD are associated with withdrawal symptoms and more severe symptoms after discontinuation, and may interfere with patients’ efforts to integrate trauma experiences. The article recommends that benzo use should be short-term for most indications, and includes some recommendations for tapering. The article appears in the April issue of Current Psychiatry.
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.